MacroGenics
MGNX
#9151
Rank
โ‚น10.60 B
Marketcap
โ‚น167.70
Share price
-5.18%
Change (1 day)
-35.41%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.58. In 2024 the company made an earnings per share (EPS) of -โ‚น98.06 a decrease over its 2023 EPS that were of -โ‚น13.75.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-94.92%
2024-โ‚น98.06613.33%
2023-โ‚น13.75-92.31%
2022-โ‚น178.70-42.14%
2021-โ‚น308.8336.44%
2020-โ‚น226.35-21.84%
2019-โ‚น289.59-24.58%
2018-โ‚น383.98675.93%
2017-โ‚น49.49-68.05%
2016-โ‚น154.87168.25%
2015-โ‚น57.73-55%
2014-โ‚น128.303400%
2013-โ‚น3.67-108.68%
2012โ‚น42.2424.49%
2011โ‚น33.93

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น157.62-3,540.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,880-41,136.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,194-26,160.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น597.50-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น695.90-15,287.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น272.17-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น162.20 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA